Non-motor symptoms in Parkinson’s disease and putamen dopamine transporter uptake (DaTscan) uptake: a survey of 85 patients
Objective: We addressed association between 30 non-motor symptoms (NMS) (using the validated Parkinson’s disease (PD) NMS Scale (NMSS)), and DaTscan putamen uptake ratios as part…The influence of LRRK2 mutations on cholinergic system in manifest and prodromal stage of Parkinson’s disease: a positron emission tomography study
Objective: To evaluate the effects of leucine-rich repeat kinase 2 (LRRK2) mutations on the central cholinergic system in both manifesting and non-manifesting carriers using PET…Modulation of executive motor network after neurofeedback training in Parkinson’s disease
Objective: To identify changes in effective (i.e. directed) connectivity in the executive motor network during finger tapping. To compare the effects of two rehabilitation strategies. …Volume analysis and localization of midbrain hyperechogenecities via TCS and MRI
Objective: We are presenting follow-up results on our previous study for 3D volumetric measurements of SN hyper-echogenicities, to differentiate PD patients from healthy controls (HC).…Changes in saccade performance with oculomotor task repetition in neurological disorders
Objective: To investigate short-term changes in saccade performance associated with repeated performance of oculomotor tasks in various neurological disorders and to elucidate the underlying neural…Two ethnic clusters with Huntington’s disease in Israel – The case of Mountain Jews and Karaites
Objective: To Assess frequencies of Huntington disease among different Israeli sub-populations Background: Worldwide prevalence estimates of Huntington's disease (HD) vary widely with no reliable information…Experience and outcomes of the first Movement Disorders Clinic in Honduras.
Objective: To describe the frequency and clinical characteristics using standardized scales in patients with movement disorders (MD) recruited by a referral system in Tegucigalpa, Honduras.…Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation
Objective: To study plasma PP concentration during sham feeding in PD patients and healthy controls, as a measure of pancreatic vagal innervation. Background: Most patients…The influence of sleep disordered breathing in REM sleep behavior disorder associated symptoms
Objective: To compare the intensity of non-motor symptoms between REM sleep behavioral disorder (RBD) patients with and without Obstructive Sleep Apnea (OSA). Background: In RBD…Speech Markers Estimate Motor Severity and Global Cognition in Parkinson’s Disease
Objective: To utilize free speech characteristics to develop markers of motor and cognitive status in Parkinson’s disease (PD). Background: Vocal biomarkers based on speech volume,…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 155
- Next Page »
